Novo Kidney Trial Finds Ozempic Cuts Cardiac Risks in Diabetics Novo Kidney Trial Finds Ozempic Cuts Cardiac Risks in Diabetics

Novo Nordisk ' s widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of...Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Diabetes & Endocrinology Source Type: news